HuagongsheHuagongshe Chemistry Print Report · For research reference only
6-(2-Oxooxazolidin-3-yl)nicotinic acid methyl ester → 3-{5-[4-(3,5,6-Trimethylpyridin-2-yl)piperazine-1-carbonyl]pyridin-2-yl}oxazolidin-2-one
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 6-(2-Oxooxazolidin-3-yl)nicotinic acid methyl ester | HCID 58484495 | — |
| Reactant | 1-(3,5,6-Trimethylpyridin-2-yl)piperazine hydrochloride | HCID 67381052 | — |
| Product | 3-{5-[4-(3,5,6-Trimethylpyridin-2-yl)piperazine-1-carbonyl]pyridin-2-yl}oxazolidin-2-one | HCID 58484509 | 21.4% |
Reaction Steps
By reaction and treatment in the same manner as in Example 63 and using 6-(2-oxooxazolidin-3-yl)nicotinic acid methyl ester (250 mg) described in Preparation Example 138 and 1-(3,5,6-trimethylpyridin-2-yl)piperazine hydrochloride (328 mg) described in Preparation Example 52 after neutralization and conversion to a free form, the title compound (95 mg) was obtained.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08354401B2 |
| Source dataset | uspto-grants-2013_01 |
| ORD ID | ord-991e4ba0dd4146118d756ce55efd46ae |
| Source note | uspto-grants-2013_01 |